₨ Official DRAP price
PKR 496.68
30's
PKR 16.56 / tablet
✓ DRAP listed · Verified 2026-08-09
Price Intelligence
Equivalent price position
Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →
This brandPKR 16.56/ tablet
Price position6% below medianvs like-for-like peer median
Peer comparators48current-price listings
🔒
MedInfoBase Pharma Pro
View Price Intelligence PRO
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Rank & percentilePeer medianFull competitor listPortfolio intelligence
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Ribavirin
- Therapeutic area
- Anti-infectives
- Drug class
- Antivirals
- ATC
- —
- Strength
- 400 mg
- Dosage form
- Tablet
- Pack
- 30's
- Registration no.
- 084485
- Verification
- 2026-08-09
Manufacturer
Next Pharmaceutical Products (Pvt.) Ltd
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Traceability
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 496.68 | 2026-07-27 | 2026-08-09 | DRAP PharmaPrice Index | Current |
Same generic
Other listed brands
Alcorib 500 mgThe Searle Company Limited · PKR 874.41Alcorib 600 mgThe Searle Company Limited · PKR 981.04Alcorib 400 mgThe Searle Company Limited · PKR 185.88Anti- C 100 mgWerrick Pharmaceuticals · PKR 225.24Anti- C 200 mgWerrick Pharmaceuticals · PKR 422.32Anti- C 600 mgWerrick Pharmaceuticals · PKR 1,178.97Anti- C 400 mgWerrick Pharmaceuticals · PKR 791.85Aviral 100 mgPharmatec Pakistan (Pvt.) Limited · PKR 330.45
Price note: Unit-price comparisons are informational calculations from source-listed pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.